Article Sidebar

Submitted
Apr 21, 2021
Published
Apr 21, 2021
Download
PDF
Statistic
Read Counter : 51 Download : 28

Main Article Content

Abstract

The main objective of the study was to investigate about the antihyperlipidemic activity of the ethanolic extract from the aerial parts of Clerodendrum serratum Linn (EECS). Qualitative analysis of the extract revealed that it contains glycosides, alkaloids, tannins, proteins, amino acids, phytosterol, steriods, terpenoids & saponins. Acute oral toxicity study was performed. Animals were divided into five groups. Normal control, positive control, Std-I-Rosuvastatin + 5% cholesterol diet, Extract of EECS-250 mg + 5% cholesterol diet, Extract of EECS- 500mg + 5% cholesterol diet for 12 weeks. Parameters considered for evaluation  Weight gain ,Blood samples were collected, parameters such as serum lipid profile ( TC, TG, HDL-c, LDL-c, VLDL-c), Kidney parameters (Urea, uric acid, Creatinine) and antioxidant enzymes such as (SOD, GSH, Catalase) were analysed. Findings suggested that Clerodendrum Serratum Linn. is a potent drug for hyperlipidemia, the drug extract treated groups lowers TC, TG, LDL-c & VLDL-c and increases the levels of HDL-c and antioxidant enzymes such as SOP, GSH and Catalase in all high cholesterol treated groups. Kidney parameters such as urea, creatinine and uric acid levels were decreased in all EECS treated group.

Keywords

Clerodendrum serratum Hyperlipidemia Antioxidant Cholesterol

Article Details

How to Cite
P.K. Kasthuri, Dr. V. Rajesh, S. Gomathi, & K. Karthikeyan. (2021). Evaluation of anti-hyperlipidemic activity of clerodendrum serratum linn on high cholesterol diet induced hyperlipidemia in rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(2), 179-186. https://doi.org/10.61096/ijrpp.v4.iss2.2015.179-186
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Global Strategy on Diet, Physical Activity And Health, WHO 2003.
  2. [2] Sugerman HJ, The pathophysiology of severe obesity and the effects of surgically induced weight loss. Surg Obes Relat Dis. 2005 Mar-Apr;1(2):109-19.
  3. [3] Bleich S, Cutler D, Murray C, Adams A. Why is the developed world obese? Annu Rev Public Health. 2008; 29:273-95.
  4. [4] Fontaine KR, Bartlett SJ, Barofsky I. Health-related quality of life among obese persons seeking and not currently seeking treatment. Int J Eat Disord 2000; 27: 101–105.
  5. [5] Nagdeva, Prashant kumar Katiyar, Ragini singh. Anticancer Activity of Leaves of Clerodendron Serratum Spreng. Am. J. PharmTech. Res.2012;2(4).
  6. [6] Keshavamurthy KR. Medicinal Plants of Karnataka. Karnataka State Forest department 1994, 92.
  7. [7] Mukesh Kr. Singh, Gaurav Khare, Shiv Kr. Iyer, Gotmi Sharwan and D. K. Tripathi. Clerodendrum serratum: A clinical approach. Journal of Applied Pharmaceutical Science, 2 (2), 2012, 11-15.
  8. [8] Harborne JB, Phytochemical Method, A Guide to modern techniques of plant Analysis, Springer (India) Pvt. Ltd, New Delhi, 3rd edition, 2005:5-16, 22.
  9. [9] Krishnaswamy NR, Chemistry of Natural Products, A laboratory hand book, Universities press India (Pvt.) Ltd, Hyderabad, 1st edition , 2003:15, 26-60, 70-73, 87-88.
  10. [10] Gurudeep R Chatwal, Sham K Anand, Instrumental methods of Chemical Analysis, Himalaya publishing house Mumbai, 5th revised edition, 2003:567.
  11. [11] Dr. Kasture AV, Dr. Wadodkar SG, Dr. Mahadik KR, Dr. More HN, Pharmaceutical Analysis, Nirali Prakashan, Pune, , 9th edition, 2003: vol II, 16.
  12. [12] Tijare RD, Beknal AB, Mahurkar N, Chandy V Pharmacognostical and Phytochemical Studies of Root Tubers of Asparagus Gonoclados Baker. International Journal of Pharmacognosy and Phytochemical Research 2012; 4(3);142-145.
  13. [13] Mc. Cormack T et.al., Hepatic metabolism and transporter Gene variants enhance response to rosuvastatin in patients with acute Myocardial infarction. Circ Cardiovascular Genet 2010; 3 : 276-285.
  14. [14] Sabrin R. M. Natural antihyperlipidemic agents: Current status and future perspectives. Phytopharmacology 2013, 4(3), 492-531.
  15. [15] Lin KY Contribution of HDL-Apolipoproteins to the inhibition of Low density \Lipoprotein oxidation and lipid accumulation in macrophages. journal of cellular Biochemistry 86; (2002), 258-267.
  16. [16] Kamesh V., Nephroprotective potential of Bacopa monniera on hypercholesterolemia induced nephropathy via the NO signaling pathway. Pharm Biol, Early Online: 1–8.